e-learning
resources
London 2016
Saturday, 03.09.2016
ERS/French Programme I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Syndrome obésité-hypoventilation: de la physiologie au traitementObesity hypoventilation: from pathophysiology to treatment
Jean-Paul Janssens (Geneva, Switzerland)
Source:
International Congress 2016 – ERS/French Programme I
Session:
ERS/French Programme I
Session type:
Session
Number:
115
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jean-Paul Janssens (Geneva, Switzerland). Syndrome obésité-hypoventilation: de la physiologie au traitementObesity hypoventilation: from pathophysiology to treatment. International Congress 2016 – ERS/French Programme I
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Exacerbation aiguë de la fibrose pulmonaire idiopathique: ce qu'il ne faut plus faire et ce qu'il reste à faire. / Acute exacerbation of idiopathic pulmonary fibrosis: what should not be done and what remains to be done?
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Exploration de la fonction respiratoire selon l'âge / Lung function testing and age
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020
Où en est-on dans la prise en charge de la Covid en septembre 2021 ? / Management of COVID-19: where are we ?
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Transplantation pulmonaire à l’heure de la médecine de précision Lung transplantation in the era of precision medicine
Source: International Congress 2019 – French programme 2019: Part II
Year: 2019
Diagnostic de l’EP chez la femme enceinte / Diagnosis of pulmonary embolism in pregnant women
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020
Mucoviscidose: enfin des traitements ciblés / Cystic fibrosis: targeted therapies, at last !
Source: Virtual Congress 2020 – French programme 2020: Part I
Year: 2020
Démarche de prise en charge des apnées centrales du sommeil Management of central sleep apnoea
Source: International Congress 2019 – French programme 2019: Part I
Year: 2019
Où en sommes-nous dans le dépistage du cancer bronchique? Screening for lung cancer: where are we?
Source: International Congress 2019 – French programme 2019: Part I
Year: 2019
Recommandations européennes ERS/ESC pour le diagnostic et la prise en charge de l’hypertension pulmonaireERS/ESC European guidelines for the diagnosis and treatment of pulmonary hypertension
Source: International Congress 2016 – ERS/French Programme II
Year: 2016
Coaching et prise de décision partagée dans les maladies respiratoires chroniques Coaching and shared decision-making in chronic respiratory diseases
Source: International Congress 2019 – French programme 2019: Part II
Year: 2019
Place des anti-IL5 dans les pathologies éosinophiliques (hors asthme sévère) / Anti-IL-5 therapy for indications other than severe asthma
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020
Réduction volumique par spirales dans le traitement de l’emphysème sévèreLung reduction coil treatment in severe emphysema
Source: International Congress 2016 – ERS/French Programme I
Year: 2016
Maladie thrombo-embolique: les nouvelles recommandations Thrombo-embolic disease: new recommendations
Source: International Congress 2019 – French programme 2019: Part I
Year: 2019
Cribado del cáncer de pulmón: nuevos avances
Source: International Congress 2014 – Session in Spanish "Sesión conjunta en castellano organizada por la ALAT (Asociación Latinoamericana de Tórax) y la SEPAR (Sociedad Española de Enfermedades Respiratorias)"
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept